Minimal Residual Disease-Directed Therapy for Childhood Acute Myeloid Leukemia: Results of the AML02 Multicenter Trial

BACKGROUND: We sought to improve outcome of childhood acute myeloid leukemia (AML) by applying risk-directed therapy based on the genetic abnormalities of the leukemic cells and measurements of minimal residual disease (MRD) as determined by flow cytometry during treatment. METHODS: From October 13,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Rubnitz, Jeffrey E., Inaba, Hiroto, Dahl, Gary, Ribeiro, Raul C., Bowman, W. Paul, Taub, Jeffrey, Pounds, Stanley, Razzouk, Bassem I, Lacayo, Norman J., Cao, Xueyuan, Meshinchi, Soheil, Degar, Barbara, Airewele, Gladstone, Raimondi, Susana C., Onciu, Mihaela, Coustan-Smith, Elaine, Downing, James R., Leung, Wing, Pui, Ching-Hon, Campana, Dario
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3171799/
https://ncbi.nlm.nih.gov/pubmed/20451454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(10)70090-5
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg